Areas of Focus
- 肿瘤发生和靶向治疗
Academic Background & Achievements
- 博士: 北京大学
- 广州市高层次人才优秀专家,2020
- 江苏省科技进步一等奖,2016
- 高等学校科技进步一等奖,2016
- 江苏医药科技杰出青年,2015
Publications
- 靶向Otub1/c-Maf轴治疗多发性骨髓瘤。, Xu Y, Xu M, Tong J, Tang X, Chen J, Chen X, Zhang Z, Cao B, Stewart AK, Moran MF, Wu D*, Mao X*., 2021
- 泛素连接酶HERC4介导c-Maf泛素化并延缓裸鼠中多发性骨髓瘤异种移植的生长。, Zhang Z, Tong J, Tang X, Juan J, Cao B, Hurren R, Chen G, Taylor P, Xu X, Shi C, Du J, Hou J, Wang G, Wu D, Stewart A, Schimmer A, Moran M, Mao X*., 2016
- D-细胞周期素转录激活的小分子抑制剂通过磷脂酰肌醇3-激酶途径显示出在骨髓瘤和白血病中的临床前疗效。, Mao X*, Cao B, Wood TE, Hurren R, Tong J, Wang X, Wang W, Li J, Jin Y, Sun W, Spagnuolo PA, Maclean N, Moran MF, Datti A, Wrana J, Batey RA, Schimmer AD., 2011
- 氯喹抑制蛋白酶体并在白血病和骨髓瘤中显示出临床前活性。, Mao X, Li X, Sprangers M, Wang X, Vengopal A, Wood T, Zhang Y, Kuntz D, Coe E, Stewart AK, Roase D, Batey RA, Kay LE, and Schimmer AD*., 2009
- 赛庚啶在骨髓瘤和白血病中显示出临床前活性。, Mao X, Liang SB, Hurren R, Gronda M, Chow S, Xu GW, Wang X, Zavareh RB, Jamal N, Messner H, Hedley DW, Datti A, Wrana JL, Zhu Y, Shi CX, Lee K, Tiedemann R, Trudel S, Stewart AK, Schimmer AD*., 2008
- 化学生物学筛选发现通过上调泛素增加其蛋白酶体降解的糖皮质激素调节c-maf表达。, Mao X, Stewart AK, Hurren R, Datti A, Zhu X, Zhu Y, Shi C, Lee K, Tiedemann R, Eberhard Y, Trudel S, Liang S, Corey S, Gillis L, Barber DL, Wrana J, Ezzat S, and Schimmer AD*., 2007
- 去泛素化酶USP7稳定Maf蛋白以促进骨髓瘤细胞存活。, He Y, Wang S, Tong J, Jiang S, Yang Y, Zhang Z, Xu Y, Zeng Y*, Cao B*, Moran MF, Mao X*., 2020
- 抑制去泛素化酶USP9x诱导前B细胞同源框1(PBX1)降解,从而刺激前列腺癌细胞凋亡。, Liu Y, Xu X, Lin P, He Y, Zhang Y, Cao B, Zhang Z, Sethi G, Liu J, Zhou X*, Mao X*., 2019
- 跨膜蛋白TMEPAI通过促进c-Maf转录因子降解诱导骨髓瘤细胞凋亡。, Du Y, Liu Y, Xu Y, Juan J, Zhang Z, Xu Z, Cao B, Wang Q, Zeng Y*, Mao X*., 2018
- 环指蛋白RNF6作为前B细胞白血病同源框1的直接靶标诱导白血病细胞增殖。, Xu X, Han K, Tang X, Zeng Y, Lin X, Zhao Y, Zhang Z, Cao B, Wu D, Mao X*., 2016
Awards
- 广州市高层次人才优秀专家,2020
- 江苏省科技进步一等奖,2016
- 高等学校科技进步一等奖,2016
- 江苏医药科技杰出青年,2015